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A 28-year-old-man with a history of human immunodeﬁ-
ciency virus (HIV), end-stage renal disease requiring
hemodialysis, and HIV-related cardiomyopathy with a
severely reduced left ventricular ejection fraction (LVEF)
and severe tricuspid regurgitation (TR) per a transthoracic
echocardiogram (TTE) underwent implantation of a single-
chamber implantable cardioverter-deﬁbrillator (ICD) in
2009 (Riata 1581, St Jude Medical, St Paul, MN). Because
of lead failure resulting in electrical noise manifesting as
nonphysiological signals, a totally subcutaneous ICD (Bos-
ton Scientiﬁc, Inc, Natick, MA) was implanted. The patient
was referred for percutaneous extraction of the endovascular
lead because of his young age, relatively short lead dwell
time, high risk of a future blood stream infection in an HIV-
positive patient on chronic hemodialysis, and patient pref-
erence after an informed discussion of risks and beneﬁts.
The procedure was scheduled for 2 months after subcuta-
neous ICD implantation to facilitate healing of the new
device sites.
There was no ﬂuoroscopic evidence of conductor extru-
sion (Figure 1A). Examination of the pocket revealed severe
calciﬁcation of the capsule, requiring complete capsulectomy
for the removal of the ICD generator (Figure 2). A trans-
venous lead extraction procedure was performed using a
combination of a locking stylet (LLD EZ, Spectranetics,
Colorado Springs, CO) and a 14-F outer diameter SLS II
Excimer laser-powered sheath (Spectranetics). Of note, the
locking style could not be advanced past the distal coil of theABBREVIATIONS HIV ¼ human immunodeficiency virus; ICD ¼
implantable cardioverter-defibrillator; ICE ¼ intracardiac
echocardiography; IJ ¼ internal jugular; LVEF ¼ left ventricular
ejection fraction; RV ¼ right ventricular; SVC ¼ superior vena cava;
TTE¼ transthoracic echocardiogram; TR¼ tricuspid regurgitation; TV¼
tricuspid valve (Heart Rhythm Case Reports 2015;1:95–98)
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(http://creativecommons.org/licenses/by-nc-sa/3.0/).right ventricular (RV) lead. Preoperative intracardiac echo-
cardiography (ICE) imaging with an 8-F phased-array
AcuNav catheter (Acuson Corporation, Mountain View,
CA) demonstrated an LVEF of 5%–10% with spontaneous
echo contrast in the left ventricle (Figure 3A), severe TR, as
well as enhanced echogenicity at the lead-myocardial inter-
face along the inferoseptal wall (Figure 3B), suggesting a
potentially strong binding site. Antegrade laser application
advanced the sheath to the superior vena cava (SVC) where
progress was impeded. Because of the tenacious adhesion at
the RV apex, further traction resulted in severing of the lead
and the locking stylet in the SVC and the right atrium
(Figure 1B) before upsizing to a 16-F outer diameter laser-
powered sheath or rotational dilator sheath could be consid-
ered. The lead was snared from a femoral approach with a
20-mmAmplatz GooseNeck snare (ev3 Inc, Plymouth, MN),
as some of the inferiorly directed frayed conductors were
amenable to this approach. Despite reinforcement with a
steerable sheath (Agilis, St Jude Medical Inc), repeated
attempts to disengage the lead from the myocardium resulted
in removal of proximal fragments, with inability to extract
the distal portion of the lead (Figure 1C). Each attempt
resulted in severe hypotension due to partial obstruction of
the tricuspid valve (TV) annulus. This resulted in frayed ICD
conductors ﬂoating freely in the TV as well as a proximal
high-voltage coil fragment afﬁxed to the SVC (Figure 1B).
No further attempts were made at this point to discuss the
risks and beneﬁts of repeated attempts with the patient.
Postoperative ICE imaging revealed normal TV leaﬂet
morphology but worsening of TR, from severe to torrential,
on the basis of visual estimation of a dedicated echocardiog-
rapher (Figure 3D), likely secondary to the retained lead
fragment and frayed conductors restricting valve closure.
After a discussion with the patient, a decision was made for a
repeat attempt at percutaneous extraction, and this time via a
right internal jugular (IJ) approach. Preoperative ICE imag-
ing once again revealed torrential TR. Ultrasound-guided
percutaneous access to the right IJ was achieved, and a 25-
mm GooseNeck snare was advanced through a steerable
sheath (Agilis) to the right atrium (Figure 1D). Once the lead
was captured, the Agilis sheath was advanced over the leads article under the CC BY-NC-SA license
http://dx.doi.org/10.1016/j.hrcr.2014.11.003
KEY TEACHING POINTS
 The decision to extract an abandoned lead is
complex. One must weigh the risks and beneﬁts of
each approach and individualize it to each patient.
 Percutaneous lead extraction from the right
internal jugular vein is a nontraditional and
uncommon technique. In the setting of failed
subclavian or femoral extraction, this strategy
appears safe and should be considered.
 Right ventricular pacing and deﬁbrillator leads can
cause worsening of tricuspid regurgitation.
Extraction of such leads may help valvular function.
This should be one of the considerations as part of
a comprehensive lead management strategy.
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unable to advance to the lead tip. With the lead ﬁrmly
positioned at the tip of the sheath, traction was used to pull
the lead back to the TV (Figures 1E and 3E; Online
Supplemental Video 1), where it ﬁnally broke free of its
endocardial binding site. The lead and the sheath wereFigure 1 Fluoroscopic images for the extraction of an implantable cardioverte
conductors in the tricuspid valve and coil fragment along the superior vena cava,
above, (E) snare attempt with traction from above (note the deformity of the cardremoved from the body at the same time, followed by
manual pressure at the entrance site. Next, the Agilis sheath
was placed in the right femoral vein and used to snare and
remove the high-voltage coil fragment in a similar manner.
ICE imaging revealed a signiﬁcant decrease in TR immedi-
ately after the procedure compared to before the procedure
(Figure 1I). The patient was discharged home the following
day in stable condition. Follow-up TTE at 5 months revealed
TR to be mild, suggesting that much of the baseline TR was
likely caused by mechanical interaction with the RV lead
before the index procedure. Of note, the LVEF also
improved from 5%–10% to 40% (Online Supplemental
Videos 2 and 3).
Discussion
There is an increasing demand for percutaneous lead
extraction as indications have expanded and tools and
technologies have evolved.1 Lead advisories and an increase
in device-related infections are some of the reasons why
physicians are now more likely to encounter patients with
complicated management issues requiring complex and
inventive solutions.
One must always balance the risks and beneﬁts of lead
extraction vs abandonment on a case-by-case basis. In thisr-deﬁbrillator (ICD) lead: (A) baseline image, (B) broken lead with frayed
(C) snare attempt with traction from below, (D) lead fragment snared from
iac silhouette before disengagement), and (F) immediately after extraction.
Figure 2 Calciﬁed capsule surrounding the front and back of the implantable cardioverter-deﬁbrillator.
Figure 3 Intracardiac echocardiographic images for the extraction of an implantable cardioverter-deﬁbrillator (ICD) lead, with the transducer placed in the
right ventricle (RV) or right atrium (RA): (A) severe left ventricular (LV) dysfunction with left ventricular ejection fractiono5% and spontaneous echo contrast
(arrows), (B) degenerated/dysfunctional ICD lead with increased echogenicity and inhomogeneity in the RV (arrows), and (C) in the RA (arrows), (D) torrential
tricuspid regurgitation (TR) indicated by Doppler color ﬂow imaging before extraction and pulmonary artery systolic pressure estimated at 51 mmHg, (E) during
extraction of the ICD lead through the sheath with obliteration of the tricuspid valve (TV) annulus (arrow), (F) RA and RV images immediately after extraction;
(G) Gross specimen of the extracted ICD lead with frayed conductor cables, (H) Gross specimen of the RV lead tip containing myocardial tissue, and (I) severe
TR after the extraction of the ICD lead signiﬁcantly reduced severity as compared to torrential TR in panel D. Ao ¼ aorta; mv ¼ mitral valve; RVOT ¼ right
ventricular outﬂow tract.
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supported by the patient’s young age and excellent func-
tional status despite low LVEF, relatively short lead dwell
time, high risk of future systemic infection in the setting of
long-term hemodialysis and HIV, high national and interna-
tional Riata extraction success rates combined with a low
major complication rate,2 and patient preference after an
informed discussion. In addition, there is an emerging
literature on speciﬁc problems related to the Riata family
of leads, including a possible increased risk of thrombus
formation and endocarditis that may further support lead
extraction in this situation.3–5
Some experienced lead extractors have advocated the
upfront use of the 16-F outer diameter laser-powered sheath
(Spectranetics) in this setting. As there is no deﬁnitive data
regarding the safety or efﬁcacy of this approach, it has been
our strategy to start with the smallest appropriate sheath and
upsize as needed. Unfortunately, severing of the lead
occurred before this consideration. Whether the use of a
16-F sheath would have avoided this complication is unclear.
Another potential option is surgical extraction, which is
generally reserved for patients with Gram-positive bacter-
emia who have failed percutaneous approach as well as
patients with a large atrial lead-related thrombus that may
result in clinically signiﬁcant pulmonary embolism. Because
of the improved efﬁcacy and safety of percutaneous meth-
ods, this approach is rarely required.
Worsening function of the TV during lead implantation
and lead extraction has been well described.6,7 In this
particular patient with a history of left- and right-sided heart
failure and elevated pulmonary arterial pressure, the beneﬁt
of a second extraction attempt outweighed the risks of a
periprocedural complication. Interestingly, follow-up TTE
revealed TR to be mild, suggesting that the RV lead was
likely interfering with valve closure before the ﬁrst proce-
dure. While resultant TV function and LVEF both improved
beyond the patient’s baseline status, this must be interpreted
with caution, as this was not a speciﬁc indication for the
index procedure and the mechanism of this dramatic
improvement is not completely clear.
Because of the tenacious adhesion process in this patient
despite a relatively short lead dwell time, extraction via a
femoral approach failed as an inferiorly directed angle of
traction was suboptimal (Figure 1C). Extraction from above
in this situation conferred a more favorable and efﬁcientangle, which, despite the absence of countertraction with an
outer sheath secondary to technical challenges, resulted in a
successful outcome. Extreme caution is advised when simple
traction without countertraction at the binding site is used,
which is the traditional approach. Bongiorni et al8 have
recently described their 15 years’ experience of safely and
effectively performing transjugular lead extraction. Despite
this, extraction from the IJ vein is a nontraditional and
uncommon technique because of operator’s unfamiliarity. In
the case of a lead tip that is severely bound to the ventricular
myocardium requiring percutaneous snaring, this strategy
should be considered.
Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2014.
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